tiprankstipranks
Trending News
More News >
PharmX Technologies Limited (AU:PHX)
ASX:PHX
Australian Market

PharmX Technologies (PHX) Income Statement

Compare
2 Followers

PharmX Technologies Income Statement

Last quarter (Q4 2022), PharmX Technologies's total revenue was $―, a decrease of ― from previous quarter. In Q4, PharmX Technologies's net income was $―. See PharmX Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ ―$ ―$ ―$ ―
Gross Profit
$ 10.52M$ 10.77M$ 7.91M$ 8.99M
Operating Expenses
$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 2.17M$ 1.83M$ 801.00K$ 410.00K
EBITDA
$ 2.54M$ 3.32M$ 1.31M$ -125.00K
Operating Income
$ 340.00K$ -914.00K$ -1.33M$ -535.00K
Other Income/Expenses
$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―
Net Income
$ 252.00K$ 1.09M$ 176.00K$ -4.21M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

PharmX Technologies Earnings and Revenue History